A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Clinical trial NCT02129673 · COMPLETED
Trial details
- NCT number
- NCT02129673
- Sponsor
- ViSci Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-05-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.